These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 25866211)

  • 1. Recent genetic discoveries in osteoporosis, sarcopenia and obesity.
    Urano T; Inoue S
    Endocr J; 2015; 62(6):475-84. PubMed ID: 25866211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of osteoporosis.
    Urano T; Inoue S
    Biochem Biophys Res Commun; 2014 Sep; 452(2):287-93. PubMed ID: 25139232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Wnt signaling molecules related to osteoporosis].
    Kubota T; Ozono K
    Clin Calcium; 2013 Jun; 23(6):855-60. PubMed ID: 23719498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiology of bone and joint disease - the present and future - . Molecular epidemiology of osteoporosis].
    Urano T
    Clin Calcium; 2014 May; 24(5):685-93. PubMed ID: 24769679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variation in Wnt/β-catenin and ER signalling pathways in female and male elite dancers and its associations with low bone mineral density: a cross-section and longitudinal study.
    Amorim T; Durães C; Machado JC; Metsios GS; Wyon M; Maia J; Flouris AD; Marques F; Nogueira L; Adubeiro N; Koutedakis Y
    Osteoporos Int; 2018 Oct; 29(10):2261-2274. PubMed ID: 29978256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
    Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
    Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of genetic and epigenetic mechanisms to Wnt pathway activity in prevalent skeletal disorders.
    García-Ibarbia C; Delgado-Calle J; Casafont I; Velasco J; Arozamena J; Pérez-Núñez MI; Alonso MA; Berciano MT; Ortiz F; Pérez-Castrillón JL; Fernández AF; Fraga MF; Zarrabeitia MT; Riancho JA
    Gene; 2013 Dec; 532(2):165-72. PubMed ID: 24096177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of the Wnt/LRP5/β-catenin signaling pathway on the pathogenesis of postmenopausal osteoporosis].
    Wang Y; Liu Y; Ma JX; Li BX; Li YK
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):769-72. PubMed ID: 22321352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variation in the Kozak sequence of WNT16 results in an increased translation and is associated with osteoporosis related parameters.
    Hendrickx G; Boudin E; Fijałkowski I; Nielsen TL; Andersen M; Brixen K; Van Hul W
    Bone; 2014 Feb; 59():57-65. PubMed ID: 24185276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic control of susceptibility to osteoporosis.
    Ralston SH
    J Clin Endocrinol Metab; 2002 Jun; 87(6):2460-6. PubMed ID: 12050200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Genetics of osteoporosis].
    Urano T
    Nihon Rinsho; 2011 Jul; 69(7):1315-21. PubMed ID: 21774378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple analyses of large-scale genome-wide association study highlight new risk pathways in lumbar spine bone mineral density.
    Wei J; Li M; Gao F; Zeng R; Liu G; Li K
    Oncotarget; 2016 May; 7(21):31429-39. PubMed ID: 27119226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis.
    de Rooy DP; Yeremenko NG; Wilson AG; Knevel R; Lindqvist E; Saxne T; Krabben A; Leijsma MK; Daha NA; Tsonaka S; Zhernakova A; Houwing-Duistermaat JJ; Huizinga TW; Toes RE; Baeten DL; Brouwer E; van der Helm-van Mil AH
    Ann Rheum Dis; 2013 May; 72(5):769-75. PubMed ID: 23041840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the genetics of osteoporosis from recent genome-wide association studies.
    Zheng HF; Spector TD; Richards JB
    Expert Rev Mol Med; 2011 Aug; 13():e28. PubMed ID: 21867596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress in understanding the genetic susceptibility to osteoporosis.
    Zmuda JM; Cauley JA; Ferrell RE
    Genet Epidemiol; 1999; 16(4):356-67. PubMed ID: 10207717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FAM210A is a novel determinant of bone and muscle structure and strength.
    Tanaka KI; Xue Y; Nguyen-Yamamoto L; Morris JA; Kanazawa I; Sugimoto T; Wing SS; Richards JB; Goltzman D
    Proc Natl Acad Sci U S A; 2018 Apr; 115(16):E3759-E3768. PubMed ID: 29618611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three pleiotropic loci associated with bone mineral density and lean body mass.
    Zhang YX; Zhang SS; Ran S; Liu Y; Zhang H; Yang XL; Hai R; Shen H; Tian Q; Deng HW; Zhang L; Pei YF
    Mol Genet Genomics; 2021 Jan; 296(1):55-65. PubMed ID: 32970232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of WNT/β-catenin signaling in the treatment of osteoporosis.
    Rossini M; Gatti D; Adami S
    Calcif Tissue Int; 2013 Aug; 93(2):121-32. PubMed ID: 23748710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Wnt-beta-catenin signaling in bone metabolism].
    Urano T
    Clin Calcium; 2006 Jan; 16(1):54-60. PubMed ID: 16397351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role of Wnt/β-catenin pathway and LRP5 protein in metabolism of bone tissue and osteoporosis etiology].
    Wolski H; Drwęska-Matelska N; Seremak-Mrozikiewicz A; Łowicki Z; Czerny B
    Ginekol Pol; 2015 Apr; 86(4):311-4. PubMed ID: 26117992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.